Amgen 386 for Recurrent Glioblastoma

 
Sponsors and Collaborators
Duke University
Amgen
 
Contact
Susan Boulton
919-668-0896
 
Karen Carter
919-668-2329
 
Principal Investigators
David Reardon, MD
Duke University Health System
 
ClinicalTrials.gov Identifier
NCT01290263